Lung Density Analysis vs Steth IO
AI Verdict
Choose Lung Density Analysis if…
Choose IMBIO's Lung Density Analysis if your practice requires advanced, quantitative analysis and 3D visualization of lung conditions from CT scans. This AI-driven software is ideal for specialists managing chronic lung diseases like COPD and emphysema, or for integrating detailed lung density reports into lung cancer screening programs, providing objective data for personalized patient care.
View Lung Density Analysis →Choose Steth IO if…
Choose Steth IO by STRATOSCIENTIFIC if your healthcare setting prioritizes real-time auscultation, remote patient monitoring, and telemedicine capabilities using a mobile device. This smartphone stethoscope is perfect for clinicians needing to quickly hear, visualize, record, and securely share heart and lung sounds during in-person visits or virtual consultations, enhancing diagnostic accuracy at the point of care and facilitating comprehensive remote patient management.
View Steth IO →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Lung Density Analysis | Steth IO |
|---|---|---|
| Pricing | Unknown | Customized pricing; subscription-based for steth io spot. |
| Deployment | Unknown | Mobile app, Cloud-based system. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Steth IOSteth IO leverages a familiar smartphone interface, transforming it into a diagnostic tool that is highly portable and accessible for real-time patient interaction and telemedicine. Its mobile-first design and intuitive app-based workflow offer broader and more immediate usability compared to the specialized integration required for Lung Density Analysis.
Clinical Value
Lung Density AnalysisLung Density Analysis provides deep, quantitative analysis and 3D visualization from CT scans, offering objective data crucial for precise diagnosis, staging, and management of complex lung diseases like COPD and emphysema. Its validation for low-dose CT scans in lung cancer screening further underscores its specific and high-impact clinical utility.
Pricing & Value
Steth IOSteth IO offers greater transparency with publicly disclosed pricing for its 'Steth IO Spot' annual membership, including a clear monthly cost and initial free months with device purchase. In contrast, Lung Density Analysis requires direct contact for pricing, which typically indicates a less transparent and potentially higher-cost enterprise solution.
Enterprise Readiness
Lung Density AnalysisLung Density Analysis explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside diverse deployment options including PACS integration and local virtualization. Steth IO's disclaimer that the 'user is responsible for compliance' and a HIPAA warning for email export presents a significant hurdle for enterprise adoption.
Innovation
Steth IOSteth IO demonstrates a more disruptive innovation by transforming a ubiquitous personal device (smartphone) into an FDA-cleared diagnostic stethoscope, complete with real-time visualization and telemedicine capabilities. This approach fundamentally redefines a traditional medical tool, making advanced auscultation more accessible and integrated into modern digital health workflows.
Support & Docs
Lung Density AnalysisIMBIO offers comprehensive support channels including dedicated phone lines, email, and an online case submission system with specified support hours. While Steth IO provides email support and user manuals, IMBIO's structured and multi-channel approach suggests a more robust and readily available support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Lung Density Analysis | Steth IO |
|---|---|---|
| Description | AI-driven medical imaging software for quantitative analysis and 3D visualization of lung conditions from CT scans, aiding in diagnosis and management of diseases like COPD and emphysema. Offers automated workflows and detailed reports for personalized patient care. | FDA-cleared smartphone stethoscope that transforms a mobile device into a powerful diagnostic aid. It enables healthcare providers to hear, visualize, record, and share heart and lung sounds in real-time, enhancing diagnostic accuracy and facilitating advanced telemedicine and remote patient monitoring for comprehensive patient care. |
| Company | IMBIO | STRATOSCIENTIFIC |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM) |
| Specialties | Pulmonology, Radiology | Cardiology, Internal Medicine, Pulmonology |
| Key Features | Automated detection, visualization, and quantification of emphysema; Validated for low-dose CT scans in lung cancer screening; Patient-centered LungMapu2122 report for smoking cessation counseling; Fully automated quantitative analysis and 3D visualization to PACS; Imbio Noise Reduction Technology (NRT) for low dose scans; Mapping of normal lung, air-trapping, and emphysema (Functional LDA); Advanced density analysis for COPD, Asthma, BOS; Quantitative reports with coronal, axial, sagittal visuals and bar charts. | Smartphone-powered stethoscope hardware and app; Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram); Record and save patient exams; Share exams with specialists/other healthcare providers; Digital filters for sound enhancement and ambient noise attenuation; Annotation tool for adding notes to exams; Telemedicine capabilities (live auscultation, video calls, scheduling); Remote patient monitoring. |
Videos
Demos, reviews, and walkthroughs featuring Lung Density Analysis and Steth IO.